跳至主要内容
临床试验/NCT02548091
NCT02548091Unknown不适用

Evaluation of the Effectiveness of Non-invasive Ventilation on the Reperfusion Pulmonary Oedema Post Pulmonary Artery Angioplasty in the Post Embolic Pulmonary Hypertension

Centre Chirurgical Marie Lannelongue1 个研究点 分布在 1 个国家目标入组 236 人开始时间: 2016年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
236
试验地点
1
主要终点
Lung Injury Score.

研究概览

简要总结

The purpose of this study is to determine whether Non Invasive Ventilation are effective in prevention of reperfusion pulmonary edema after pulmonary artery angioplasty. Our hypothesis is that administration of Non Invasive Ventilation during the procedure and systematically in post procedure period is a protective factor against the development and severity of reperfusion pulmonary edema.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age ≥ 18 years
  • •First and /or second procedure of pulmonary artery angioplasty
  • •Mean pulmonary arterial pressure ≥ 40 mmHg and/or pulmonary vascular resistance ≥ 8 WU (Wood unit)
  • •Patient who signed informed consent
  • •Patients affiliated to a social security program

排除标准

  • •severe neurological disease: Coma Glasgow Scale < 8, severe cognitive decline, postural instability, loss of autonomy.
  • •psychiatric disease (illness)
  • •sepsis, severe sepsis and septic shock, according to definitions and diagnostic criteria for sepsis of 'Surviving Sepsis Campaign 2012'
  • •severe respiratory failure defined by a total lung capacity (TLC)< 50% of the predicted value and/or expiratory volume in 1 second (FEV) < 30% of predicted value
  • •obstructive sleep apnea syndrome with Continuous Positive Airway treatment
  • •preexisting hemorrhagic syndrome or coagulation factors deficiency
  • •severe renal insufficiency with glomerular filtration rate < 30 ml/min
  • •severe hepatic failure with hepatic encephalopathy, hemodynamic disorder, decompensates cirrhosis, metabolic disorder( metabolic acidosis, hypoglycemia) hepatorenal syndrome, coagulation disorder (factor V< 50%,disseminated intravascular coagulation)
  • •patient refusal of participation in the study program
  • •subjects not affiliated to social security program

研究组 & 干预措施

Preventive non invasive ventilation

Active Comparator

Patients will receive the non invasive ventilation (NIV) systematically during the whole procedure of pulmonary angioplasty, and then systematically in post procedure period, 1 hour every 4 hours, during the whole hospitalization in post anesthesia care unit (PACU).

干预措施: Non invasive ventilation (Procedure)

Preventive non invasive ventilation

Active Comparator

Patients will receive the non invasive ventilation (NIV) systematically during the whole procedure of pulmonary angioplasty, and then systematically in post procedure period, 1 hour every 4 hours, during the whole hospitalization in post anesthesia care unit (PACU).

干预措施: monitoring system Pulse-Induced Contour Cardiac Output (Picco) (Procedure)

Preventive non invasive ventilation

Active Comparator

Patients will receive the non invasive ventilation (NIV) systematically during the whole procedure of pulmonary angioplasty, and then systematically in post procedure period, 1 hour every 4 hours, during the whole hospitalization in post anesthesia care unit (PACU).

干预措施: Computed tomography (CT) (Procedure)

Preventive non invasive ventilation

Active Comparator

Patients will receive the non invasive ventilation (NIV) systematically during the whole procedure of pulmonary angioplasty, and then systematically in post procedure period, 1 hour every 4 hours, during the whole hospitalization in post anesthesia care unit (PACU).

干预措施: Blood samples for assays of plasma inflammatory markers (cytokines InterLeukin-6, InterLeukin-8, InterLeukin-10) (Other)

Non invasive ventilation on demand

Other

Patients will not receive the NIV during the procedure of pulmonary angioplasty; in case of respiratory decompensation in post procedure period they will receive NIV during the whole hospitalization in PACU according to the following criteria: paradoxical breathing, respiratory rate above 25/minutes, a ratio of arterial oxygen pressure to fraction of inspired oxygen values (PaO2/FiO2) below 200.

干预措施: monitoring system Pulse-Induced Contour Cardiac Output (Picco) (Procedure)

Non invasive ventilation on demand

Other

Patients will not receive the NIV during the procedure of pulmonary angioplasty; in case of respiratory decompensation in post procedure period they will receive NIV during the whole hospitalization in PACU according to the following criteria: paradoxical breathing, respiratory rate above 25/minutes, a ratio of arterial oxygen pressure to fraction of inspired oxygen values (PaO2/FiO2) below 200.

干预措施: Computed tomography (CT) (Procedure)

Non invasive ventilation on demand

Other

Patients will not receive the NIV during the procedure of pulmonary angioplasty; in case of respiratory decompensation in post procedure period they will receive NIV during the whole hospitalization in PACU according to the following criteria: paradoxical breathing, respiratory rate above 25/minutes, a ratio of arterial oxygen pressure to fraction of inspired oxygen values (PaO2/FiO2) below 200.

干预措施: Blood samples for assays of plasma inflammatory markers (cytokines InterLeukin-6, InterLeukin-8, InterLeukin-10) (Other)

Non invasive ventilation on demand

Other

Patients will not receive the NIV during the procedure of pulmonary angioplasty; in case of respiratory decompensation in post procedure period they will receive NIV during the whole hospitalization in PACU according to the following criteria: paradoxical breathing, respiratory rate above 25/minutes, a ratio of arterial oxygen pressure to fraction of inspired oxygen values (PaO2/FiO2) below 200.

干预措施: Non invasive ventilation (Procedure)

结局指标

主要结局

Lung Injury Score.

时间窗: Daily during hospitalization in the PACU on day 1 to 7.

次要结局

  • Computed tomography (CT) score(2 years)
  • Pulmonary Vascular Index (PVI) measures(2 years)
  • Doppler pulsatility of the portal vein and its pulsatility ratio(2 years)
  • Assays of plasma inflammatory markers (InterLeukin-6 , IInterLeukin-8, InterLeukin-10).(2 years)
  • Extravascular Lung Water (EVLW) measures.(2 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验